HDAC6 deacetylates α-tubulin and regulates cytoskeletal dynamics. HDAC6 overexpression causes axonal transport defects. Selective HDAC6 inhibition restores acetylated tubulin levels, improves axonal transport, and delays disease progression in CMT2A and SOD1 mouse models.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
LysosomalUnspecified Mechanismneurodegeneration
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
7/11
dimensions won
LRRK2 G2019S Kinase Inhibition for Parki
6/11
dimensions won
HDAC6 Inhibition for Charcot-Marie-Tooth
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.82
0.78
Evidence
0.85
0.80
Novelty
0.65
0.68
Feasibility
0.90
0.85
Impact
0.80
0.82
Druggability
0.95
0.88
Safety
0.65
0.70
Competition
0.60
0.75
Data
0.88
0.82
Reproducible
0.85
0.85
KG Connect
0.50
0.50
Score Breakdown
Dimension
LRRK2 G2019S Kinase Inhibition
HDAC6 Inhibition for Charcot-M
Mechanistic
0.820
0.780
Evidence
0.850
0.800
Novelty
0.650
0.680
Feasibility
0.900
0.850
Impact
0.800
0.820
Druggability
0.950
0.880
Safety
0.650
0.700
Competition
0.600
0.750
Data
0.880
0.820
Reproducible
0.850
0.850
KG Connect
0.500
0.500
Evidence
LRRK2 G2019S Kinase Inhibition for Parkinson's Disease
No evidence citations yet
HDAC6 Inhibition for Charcot-Marie-Tooth Disease and ALS
No evidence citations yet
Debate Excerpts
LRRK2 G2019S Kinase Inhibition for Parkinson's Dis
4 rounds · quality: 0.77
Persona-Theorist
# Therapeutic Hypotheses in Neurodegeneration
## Hypothesis 1: TREM2 Microglial Activation as Disease-Modifying Target in Alzheimer's Disease
**Mechanism:** TREM2 is a surface receptor on microglia ...
Persona-Skeptic
# Skeptical Critique: Therapeutic Hypotheses in Neurodegeneration
## Hypothesis 1: TREM2 Microglial Activation in AD
### Critical Weaknesses
**1. Contradictory TREM2 biology**
While TREM2 R47H in...
Persona-Domain Expert
# Domain Expert Feasibility Assessment: Neurodegeneration Therapeutic Hypotheses
## Executive Summary
After reviewing the Theorist's proposals and Skeptic's critiques, I assess development feasibili...
HDAC6 Inhibition for Charcot-Marie-Tooth Disease a
4 rounds · quality: 0.77
Persona-Theorist
# Therapeutic Hypotheses in Neurodegeneration
## Hypothesis 1: TREM2 Microglial Activation as Disease-Modifying Target in Alzheimer's Disease
**Mechanism:** TREM2 is a surface receptor on microglia ...
Persona-Skeptic
# Skeptical Critique: Therapeutic Hypotheses in Neurodegeneration
## Hypothesis 1: TREM2 Microglial Activation in AD
### Critical Weaknesses
**1. Contradictory TREM2 biology**
While TREM2 R47H in...
Persona-Domain Expert
# Domain Expert Feasibility Assessment: Neurodegeneration Therapeutic Hypotheses
## Executive Summary
After reviewing the Theorist's proposals and Skeptic's critiques, I assess development feasibili...